| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.84 | 0.0006 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |